INGN Inogen Inc.

Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018

GOLETA, Calif.--(BUSINESS WIRE)--

Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2018 financial results after market close on Monday, April 30, 2018. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (855) 238-8123 for domestic callers or (412) 317-5217 for international callers. Please reference Inogen (INGN) to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.

A replay of the call will be available beginning, April 30, 2018 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on May 7, 2018. To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference Access Code: 10118964. The webcast will also be available on Inogen's website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

EN
19/04/2018

Underlying

INGNInogen Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inogen Inc.

 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording o...

April 10, 2024 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 9, 2024, at 9:30 a.m. Eastern Time. A live audio webcast and archived recording of the presentation will be available to all interested parties through the page on the Inogen web...

March 25, 2024 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(...

GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity aw...

March 7, 2024 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)-- . (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full-year ended December 31, 2023. “I am excited for the future of Inogen. As we progress into 2024, we are focused on positioning the business for revenue growth and long-term profitability while advancing our innovation pipeline and working to bring Physio-Assist to the U.S. market,” said Kevin Smith, President and Chief Executive Officer. “We have a strong management team with...

February 27, 2024 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results o...

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. To listen to a live webc...

January 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch